TW286273B - - Google Patents

Info

Publication number
TW286273B
TW286273B TW083105534A TW83105534A TW286273B TW 286273 B TW286273 B TW 286273B TW 083105534 A TW083105534 A TW 083105534A TW 83105534 A TW83105534 A TW 83105534A TW 286273 B TW286273 B TW 286273B
Authority
TW
Taiwan
Prior art keywords
pct
core member
support means
sec
delivery
Prior art date
Application number
TW083105534A
Other languages
English (en)
Chinese (zh)
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of TW286273B publication Critical patent/TW286273B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
  • Paper (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
  • Details Of Garments (AREA)
  • Particle Formation And Scattering Control In Inkjet Printers (AREA)
TW083105534A 1993-06-17 1994-06-15 TW286273B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi

Publications (1)

Publication Number Publication Date
TW286273B true TW286273B (enExample) 1996-09-21

Family

ID=8538154

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083105534A TW286273B (enExample) 1993-06-17 1994-06-15

Country Status (24)

Country Link
US (1) US5694947A (enExample)
EP (1) EP0703802B1 (enExample)
JP (1) JP3803714B2 (enExample)
KR (1) KR100312764B1 (enExample)
CN (1) CN1126574C (enExample)
AT (1) ATE177657T1 (enExample)
AU (1) AU674758B2 (enExample)
BR (1) BR9407118A (enExample)
CZ (1) CZ284989B6 (enExample)
DE (1) DE69417232T2 (enExample)
DK (1) DK0703802T3 (enExample)
EE (1) EE03202B1 (enExample)
ES (1) ES2130423T3 (enExample)
FI (1) FI95768C (enExample)
GR (1) GR3030565T3 (enExample)
HU (1) HU217950B (enExample)
LT (1) LT3455B (enExample)
LV (1) LV12452B (enExample)
MY (1) MY113965A (enExample)
NO (1) NO311498B1 (enExample)
PL (1) PL176664B1 (enExample)
RU (1) RU2121824C1 (enExample)
TW (1) TW286273B (enExample)
WO (1) WO1995000199A1 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
JP2002513690A (ja) * 1998-05-01 2002-05-14 エフイ−アイ エンタープライジズ,リミティド 制御放出デバイスの射出成形製造方法
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
CN1289064C (zh) * 2001-08-31 2006-12-13 先灵有限责任公司 药物输送体系
CA2531640C (en) * 2003-07-10 2013-06-18 Galen (Chemicals) Limited Intravaginal drug delivery devices
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
ATE495752T1 (de) 2005-07-19 2011-02-15 Population Council Inc Verfahren und zusammensetzungen zur notfallbedingten verhütung mithilfe von endothelin-rezeptor-antagonisten
CA2646593C (en) * 2006-03-20 2015-12-08 Duramed Pharmaceuticals, Inc. Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
US20100136090A1 (en) * 2006-11-20 2010-06-03 N.V. Organon; Intervet International B.V. Helically-Shaped Drug Delivery System
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
EP2244782A4 (en) * 2008-01-25 2011-09-14 Univ Utah Res Found POLYMER WITH LINEAR ORDER RELEASE
WO2009099586A2 (en) 2008-02-04 2009-08-13 Duramed Pharmaceuticals, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI20095563A7 (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2749286B1 (en) 2011-08-26 2017-03-01 Universidad De Santiago De Chile Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process
GB201115592D0 (en) * 2011-09-09 2011-10-26 Vivosens Medical Gmbh Flexible ring pessary
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
CN103007427B (zh) * 2011-09-21 2016-01-20 上海市计划生育科学研究所 缓控释宫内释药器及其制备方法
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2641602A1 (en) 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2893804T (pt) 2012-09-03 2018-06-26 Ecosea Farming S A Sistema de imersão de um reservatório-jaula destinado à cultura e/ou contenção de espécies hidrobiológicas
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MY181448A (en) 2013-04-10 2020-12-22 Preglem Sa Progesteron receptor modulators for use in the therapy of uterine fibroids
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
JP6667450B2 (ja) * 2014-04-01 2020-03-18 ポリ−メッド インコーポレイテッド 避妊具及び関連した器具
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
KR20230142816A (ko) 2014-06-26 2023-10-11 타리스 바이오메디컬 엘엘씨 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN110403565B (zh) * 2018-04-27 2022-02-11 西安交通大学医学院第一附属医院 一种胶囊内窥镜磁与麦芒仿生双驱动装置
CN109771124A (zh) * 2019-01-31 2019-05-21 山东省药学科学院 一种具有形状记忆功能的子宫托
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1264731A (en) * 1917-03-19 1918-04-30 Carl Willers Pneumatic die-cushion.
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3911911A (en) * 1969-06-16 1975-10-14 Reese Hospital Michael Anti-fertility device
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
GB1465684A (en) * 1973-07-27 1977-02-23 Emmett L Contraceptive device
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE2616064A1 (de) * 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
DE3175137D1 (en) * 1981-12-30 1986-09-18 Population Council Inc Method of making intrauterine devices
JPS5919151U (ja) * 1982-07-28 1984-02-06 ニツポ−株式会社 痔疾治療器
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4822161A (en) * 1988-01-19 1989-04-18 Jimmy Michael F Illuminating spectacle apparatus
JPH02185264A (ja) * 1988-12-16 1990-07-19 Ferring Bv 膀胱内又は尿管へ薬を送り込む方法及び装置
KR100236355B1 (ko) * 1990-03-16 2000-01-15 이데이 노부유끼 와이프 패턴의 발생장치
JP3186105B2 (ja) * 1991-07-26 2001-07-11 日本電気株式会社 半導体装置のテストモード設定・解除回路
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
MY113965A (en) 2002-07-31
NO311498B1 (no) 2001-12-03
JPH08511240A (ja) 1996-11-26
DE69417232D1 (de) 1999-04-22
NO955029D0 (no) 1995-12-12
CZ320895A3 (en) 1996-07-17
EP0703802A1 (en) 1996-04-03
PL176664B1 (pl) 1999-07-30
LV12452A (lv) 2000-04-20
WO1995000199A1 (en) 1995-01-05
HU217950B (hu) 2000-05-28
AU674758B2 (en) 1997-01-09
NO955029L (no) 1995-12-12
GR3030565T3 (en) 1999-10-29
LT3455B (en) 1995-10-25
DE69417232T2 (de) 1999-11-04
LV12452B (en) 2000-09-20
CN1125403A (zh) 1996-06-26
BR9407118A (pt) 1996-09-03
HU9503290D0 (en) 1996-01-29
ATE177657T1 (de) 1999-04-15
FI95768B (fi) 1995-12-15
KR960703024A (ko) 1996-06-19
FI932789A0 (fi) 1993-06-17
CN1126574C (zh) 2003-11-05
RU2121824C1 (ru) 1998-11-20
FI95768C (fi) 1996-03-25
KR100312764B1 (ko) 2002-11-23
AU6848194A (en) 1995-01-17
ES2130423T3 (es) 1999-07-01
US5694947A (en) 1997-12-09
HUT74548A (en) 1997-01-28
JP3803714B2 (ja) 2006-08-02
EP0703802B1 (en) 1999-03-17
EE03202B1 (et) 1999-08-16
DK0703802T3 (da) 1999-10-11
FI932789L (fi) 1994-12-18
LTIP1957A (en) 1995-01-31
CZ284989B6 (cs) 1999-04-14
PL312193A1 (en) 1996-04-01

Similar Documents

Publication Publication Date Title
HU9503290D0 (en) Intravaginal delivery system
GR3024468T3 (en) Inhalation powder containing antistatic agent.
ZA937099B (en) Microparticle preparations made of biodegradable copolymers.
GB9203037D0 (en) Contrast agents
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
AU5110593A (en) Support catalyst and use of same
WO1997012963A3 (en) A paf-acetylhydrolase and use in therapy
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
TR199600588A2 (tr) 4-Floralkil ikame edilmis benzoilguanidin'ler, bunlarin imal edilmesine mahsus usul, bunlarin ilac ya da diyagnoz maddesi olarak kullanilmalari ve bunlari ihtiva eden ilaclar.
GR3024940T3 (en) Gestagenically active 19,11-bridged 4-estrenes.
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
GB9310400D0 (en) Curable compositions
HU9402646D0 (en) Anomere fluoro-ribosyl-amines
CA2165282A1 (en) Intravaginal delivery system
EP0634168A4 (enExample)
WO1996024378A3 (en) Delivery of exogenous compounds
MX9701031A (es) Utilizacion de la selegilina para el tratamiento de enfermedades epilepticas.
ES2141044A1 (es) Terapia con oxibutinina.
GB9315411D0 (en) Active agent delivery
FR2696066B1 (fr) Procédé pour transmettre des messages, et unité fonctionnelle et installation s'y rapportant.
UA23119A (uk) Психотропhий засіб

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees